Joanne Mortimer
City of Hope Medical Center · University of California, San Diego
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joanne Mortimer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04661982 · Long Term Follow-Up in Patients With Stage 0-IIIC Breast CancerCity of Hope Medical Center · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT04305834 · Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.City of Hope Medical Center · recruiting · Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma · principal investigator
- Ph1NCT04020575 · Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)Minerva Biotechnologies Corporation · recruiting · Metastatic Breast Cancer · principal investigator
- Ph1/Ph2NCT03853707 · Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast CancerCity of Hope Medical Center · completed · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 · principal investigator
- Ph2NCT02827877 · Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast CancerCity of Hope Medical Center · active not recruiting · HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer · principal investigator
- Ph2NCT02778685 · Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast CancerCity of Hope Medical Center · active not recruiting · Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 · principal investigator
- N/ANCT02432950 · Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerCity of Hope Medical Center · completed · Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer · principal investigator
- N/ANCT02226276 · Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast CancerCity of Hope Medical Center · active not recruiting · Bone Metastases, HER2-positive Breast Cancer, Liver Metastases · principal investigator
- Ph2NCT01730833 · Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCity of Hope Medical Center · completed · HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer · principal investigator
- Ph2NCT01525966 · Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerCity of Hope Medical Center · active not recruiting · Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer · principal investigator
- N/ANCT01409811 · Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidCity of Hope Medical Center · terminated · Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma, Progesterone Receptor-positive Breast Cancer · principal investigator
- Ph2NCT01149083 · Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast CancerNational Cancer Institute (NCI) · completed · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma · principal investigator
- N/ANCT01093612 · Positron Emission Tomography in Women With Advanced HER2-Positive Breast CancerCity of Hope Medical Center · active not recruiting · Breast Cancer, Stage IV Breast Cancer · principal investigator
- Ph2NCT00295893 · Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerCity of Hope Medical Center · active not recruiting · Breast Cancer · principal investigator
- N/ANCT00283257 · Simultaneous Care: Linking Palliation to Clinical TrialsUniversity of California, Davis · completed · Solid Tumor, Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Cancer Research Training and Education CoordinationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2018 to 2026 · $222,909 awarded in 2026Grant number is on one of their registry trials
- City of Hope Clinical Oncology Career Research Development ProgramK12CA001727 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2009 to 2024 · $773,626 awarded in 2024Same name and institution; not confirmed by an ID
- City of Hope Southwest Oncology Group Clinical TrialsU10CA046368 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2008 to 2013 · $340,319 awarded in 2013Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Role of miR-105 in breast cancer metastasisR01CA166020 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Shizhen Emily Wang · fiscal years 2012 to 2016Named on NCT01730833
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT01149083
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:56 UTC. The ranking covers the 200 most relevant of 59 PubMed records, and a shared surname and initials can bring in a namesake. All 59 on PubMed
- Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.N Engl J Med · 19981,047 citationsRCR 28.7
- A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.J Clin Oncol · 1992502 citationsRCR 14.4
- 420 citationsRCR 11.3
- Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.J Clin Oncol · 1995312 citationsRCR 9.9
- 307 citationsRCR 7.1
- 290 citationsRCR 12.3
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.Lancet Oncol · 2010228 citationsRCR 5.0
- Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.Breast Cancer Res · 2018226 citationsRCR 10.6
- Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.J Clin Oncol · 2004223 citationsRCR 4.3
- Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders.J Alzheimers Dis · 2012206 citationsRCR 7.6